Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobuline Induction in DCD Kidney Transplant
NCT03099122Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2017
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte immunoglobulin rabbit in kidney transplant rejection, sponsored by Sanofi. Started Aug 2017; status: completed.
02
Drugs
antithymocyte immunoglobulin rabbit
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03099122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03099122.